SummitTherapeutics

Summit Therapeutics stock falls as MACD Death Cross and Bollinger Bands narrow.

Summit Therapeutics: Bollinger Bands Narrowing, KDJ Death Cross on 15min Chart

Summit Therapeutics 15min chart sees Bollinger Bands Expanding Downward, KDJ Death Cross

Summit Therapeutics's 15min chart shows KDJ Death Cross, Bearish Marubozu pattern.

Summit Therapeutics 15min chart triggers Bollinger Bands Narrowing, Bearish Marubozu signal.

Catalyst<ul> <li>Most analysts rate SMMT Buy or Strong Buy, showing broad institutional optimism.</li> <li>Recent Bullish Engulfing and Long Lower Shadow signals in late November and early December point to rebound momentum for SMMT.</li></ul>Risk<ul> <li>Technical indicators show that the market is in a volatile state and the direction is not clear enough.</li> <li>Fund flow analysis indicates a negative overall trend with conflicting inflow and outflow patterns across different order sizes.</li></ul>

Key Factors

U.S. FDA has accepted Summit Therapeutics' Biologics License Application for ivonescimab with a PDUFA goal action date of November 14, 2026.

SMMT News